After adjusting for age, diabetes duration, metabolism‐related indicators, and other sex‐related hormones, FSH was inversely associated with NAFLD (odds ratio: 0.411, 95% confidence intervals: 0.260–0.651, p < .001). The gene discussed is BRD2; the disease is metabolic dysfunction-associated steatotic liver disease.